Rare clot risk linked to Johnson & Johnson COVID-19 vaccine should be explained to younger women, CDC says

Patients should be informed of a rare but serious clotting risk following vaccination with Johnson & Johnson’s single-dose COVID-19 jab, especially women under the age of 50, federal health authorities warn.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button